retatrutide phase 3 triumph TRIUMPH-4 Results: 28.7% Weight Loss & What It Means for the Peptide Industry Retatrutide Achieves Up to 28.7%

If you are unsure about your specific needs, request a referral to a dietitian through your GP

Sermorelin remains available as a compounded prescription medication through licensed pharmacies under FDA compounding regulations

This effect may be further amplified by the broader societal protein craze. Early research suggests that retail protein expenditures, particularly for meat protein, decrease following the adoption of GLP-1 medications, even though users desire and valuation of protein remain the same or increase

As a result, the critical question of whether any observed pregnancy benefit is independent of metabolic change remains unresolved

Due to large number of free fitting parameters in such models, there was considerable uncertainty in the fitted parameters

In late December 2025, the FDA approved the first oral GLP-1 medication, a Wegovy (semaglutide) pill